ArticleScientific reports2024
Optimising ovarian tumor classification using a novel CT sequence selection algorithm.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Artificial intelligence in ovarian cancer: advancing in precision diagnosis and clinical management.Frontiers in immunology · 2026Review
- Artificial Intelligence in Radiology: Advancing Precision, Accuracy, and Early Detection in Cancer Diagnosis.Cureus · 2025Review
- Multiple perception contrastive learning for automated ovarian tumor classification in CT images.Abdominal radiology (New York) · 2025Article
- A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopy.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Gynaecological cancers, especially ovarian cancer, remain a critical public health issue, particularly in regions like India, where there are challenges related to cancer awareness, variable pathology, and limited access to screening facilities. These challenges often lead to the diagnosis of cancer at advanced stages, resulting in poorer outcomes for patients. The goal of this study is to enhance the accuracy of classifying ovarian tumours, with a focus on distinguishing between malignant and early-stage cases, by applying advanced deep learning methods. In our approach, we utilized three pre-trained deep learning models-Xception, ResNet50V2, and ResNet50V2FPN-to classify ovarian tumors using publicly available Computed Tomography (CT) scan data. To further improve the model's performance, we developed a novel CT Sequence Selection Algorithm, which optimises the use of CT images for a more precise classification of ovarian tumours. The models were trained and evaluated on selected TIFF images, comparing the performance of the ResNet50V2FPN model with and without the CT Sequence Selection Algorithm. Our experimental results show the Comparative evaluation against the ResNet50V2 FPN model, both with and without the CT Sequence Selection Algorithm, demonstrates the superiority of the proposed algorithm over existing state-of-the-art methods. This research presents a promising approach for improving the early detection and management of gynecological cancers, with potential benefits for patient outcomes, especially in areas with limited healthcare resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.